1 / 9

Comprehensive Clinical Trial Insights with Clival Database

Clival Database offers unparalleled access to detailed clinical trial records, helping researchers track biomarkers in clinical trials and analyze completed clinical trials efficiently. Our platform supports clinical organizations by providing valuable data on patients in clinical trials, enabling robust and insightful analysis. Trust Clival Database for comprehensive, up-to-date information on all aspects of your clinical research needs.<br>Explore:- https://clival.com/sponsor<br>

ClivalDatabase
Download Presentation

Comprehensive Clinical Trial Insights with Clival Database

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Drug Discovery and Development Phase 1, Phase 2, Phase 3

  2. Introduction Clinical trials are a critical stage in the development of new drugs and treatments, designed to confirm their safety and effectiveness before they are approved for general use. These trials are typically divided into three main phases: Phase 1, Phase 2, and Phase 3. Each phase serves a specific purpose in the process from initial discovery of a new drug to market approval.

  3. Phase 1 clinical trials Phase 1 trials are the first step in testing a new drug or treatment in humans. These studies focus primarily on evaluating the safety of the drug and determining appropriate dosage levels. Testing is usually done in a small group of healthy volunteers (20-100 participants), but may also include patients suffering from the disease the drug is intended to treat.

  4. Phase 2 Clinical Trials If a drug shows promising safety in phase 1 trials, it moves into phase 2 trials, which involve a larger group of patients (usually several hundred people) who have the disease or condition the drug is intended to treat. Phase 2 trials are intended to further evaluate the drug's safety and begin to evaluate its effectiveness.

  5. Phase 3 clinical trials: Phase 3 trials are large-scale studies involving hundreds to thousands of patients at multiple sites and sometimes in multiple countries. These studies aim to confirm and extend the results of previous phases and evaluate the effectiveness of the drug compared to existing treatments or placebo.

  6. Drug discovery and development: 1. Discovery and Research 2. Preclinical Studies 3.Investigational New Drug (IND) Application 4. Clinical Trials (Phases 1-3): 5. Regulatory Review 6. Post-marketing surveillance

  7. Challenges and trend Challenges: • Long duration, high cost, high failure rate. • Only about 13% of compounds that enter Phase 1 trials lead to market launch. • Development cycles take 12 years on average. Trends: • Artificial intelligence (AI): Used to streamline R&D and accelerate drug development. In Vitro Technologies: New approaches to toxicity testing and efficacy evaluation. • Personalized Medicine: Customized treatment based on individual patient characteristics.

  8. Conclusion clinical trials play a central role in the drug development process by ensuring new treatments are safe, effective, and beneficial for patients. Each phase of clinical trials provides important data and insights that ultimately lead to regulatory approval and improved medical outcomes.

  9. Website:- www.clival.com Location:- C-89, Sector-65 Noida-U.P. 201301 (India) E-Mail:- info@lifescienceintellipedia.comsales@lifescienceintellipedia.com Phone:- +91-120-6631301-335 Mob No:- +91-9990237670

More Related